Companies: 10,795·Total market cap: $144.5T
Aurora Cannabis Inc.

Aurora Cannabis Inc.

ACBNASDAQHealthcare● Active
$3.41
+$0.03(+0.89%)
Market Cap$201621720
P/E Ratio
52W High$6.665
52W Low$3.07

Aurora Cannabis Inc. (ACB) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

acb · stock forecast · 14 analysts (3M) · FMP

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Hold

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
8
Sell
3
Strong Sell
0
Total: 14 · Buy rate: 21.4%

12-Month Price Target

High

$8.75

Consensus

$5.92

+73.6% upside

Low

$1.00

Median: $8 · Last Close: $3.41

The Aurora Cannabis Inc. (ACB) analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month ACB price target is $5.92, representing +73.6% upside from the current price of $3.41.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $6 (73.6%)

Consensus Target

$5.92

73.6% upside

High Target

$8.75322283

156.7%

Low Target

$1

-70.7%

Current Price

$3.41

as of today

Based on analyst price targets, the ACB stock price prediction for the next 12 months ranges from $1 to $8.75322283. The consensus ACB price forecast of $5.92 implies 73.6% upside from the current price of $3.41.

Short-Term Price Prediction

Short-term price predictions will be available once the prediction engine is ready.

Long-Term Stock Price Prediction

Long-term price predictions will be available once the prediction engine is ready.

Stock Forecast Based on Technical Analysis

Technical analysis will be available once the prediction engine is ready.

Latest Analyst Ratings & Upgrades

Filter:

Wall Street analysts have recently issued updated ratings on Aurora Cannabis Inc. (ACB) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 14 analysts currently cover ACB.

Analyst Recommendation Trends

ACB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ACB EPS of $ for the current fiscal year, based on estimates from 0 analysts. The ACB revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ACB stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ACB price target is $5.92 (+73.6% upside), with an analyst consensus of Hold.

Aurora Cannabis Inc. trades on NASDAQ under the ticker ACB. The ACB stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 21% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ACB forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month ACB price target is $5.92, with a high forecast of $8.75 and a low of $1.00. The median price target is shown in the chart above when available. This implies +73.6% potential upside from the current price of $3.41.

ACB price targetWhat is ACB price targetACB analyst price targetACB 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.